A perspective view of sodium iodide symporter research and its clinical implicationsRIESCO-EIZAGUIRRE, Garcilaso; SANTISTEBAN, Pilar.European journal of endocrinology. 2006, Vol 155, Num 4, pp 495-512, issn 0804-4643, 18 p.Article

Transcriptional regulation of human sodium/iodide symporter gene: A role for redox factor-1PUPPIN, Cinzia; ARTURI, Franco; FERRETTI, Elisabetta et al.Endocrinology (Philadelphia). 2004, Vol 145, Num 3, pp 1290-1293, issn 0013-7227, 4 p.Article

Down-regulation of the sodium/iodide symporter explains ¹³¹I-induced thyroid stunningNORDEN, Madeleine M; LARSSON, Fredrik; TEDELIND, Sofia et al.Cancer research (Baltimore). 2007, Vol 67, Num 15, pp 7512-7517, issn 0008-5472, 6 p.Article

Sodium/iodide symporter (NIS) gene expression is the limiting step for the onset of thyroid function in the human fetusSZINNAI, Gabor; LACROIX, Ludovic; SCHLUMBERGER, Martin et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 1, pp 70-76, issn 0021-972X, 7 p.Article

Application of the Cre/loxP system to enhance thyroid-targeted expression of sodium/iodide symporterXIAOQIN LIN; FISCHER, Andrew H; RYU, Kwon-Yul et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 5, pp 2344-2350, issn 0021-972X, 7 p.Article

Le symporteur sodium/iodure : données récentes et perspectives thérapeutiques = Sodium/iodide symporter : physiopathological aspects and therapeutic perspectivesPLANTIN-CARRENARD, E; FOGLIETTI, M.-J; BEAUDEUX, J.-L et al.Pathologie et biologie. 2005, Vol 53, Num 3, pp 174-182, issn 0369-8114, 9 p.Article

Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumorsTROUTTET-MASSON, Séverine; SELMI-RUBY, Samia; BORSON-CHAZOT, Francoise et al.The American journal of pathology. 2004, Vol 165, Num 1, pp 25-34, issn 0002-9440, 10 p.Article

The sodium-iodide symporter expression in placental tissue at different gestational age : an immunohistochemical studyDI COSMO, C; FANELLI, G; NACCARATO, A. G et al.Clinical endocrinology (Oxford. Print). 2006, Vol 65, Num 4, pp 544-548, issn 0300-0664, 5 p.Article

Visualization of endogenous p53-mediated transcription In vivo using sodium iodide symporterKWANG IL KIM; CHUNG, June-Key; JOO HYUN KANG et al.Clinical cancer research. 2005, Vol 11, Num 1, pp 123-128, issn 1078-0432, 6 p.Article

Rat sodium iodide symporter for radioiodide therapy of cancerMITROFANOVA, Elena; UNFER, Robert; VAHANIAN, Nick et al.Clinical cancer research. 2004, Vol 10, Num 20, pp 6969-6976, issn 1078-0432, 8 p.Article

The sodium-iodide symporter protein is always present at a low expression and confined to the cell membrane in nonfunctioning nonadenomatous nodules of toxic nodular goitreTONACCHERA, Massimo; VIACAVAT, Paolo; FANELLIT, Giovanni et al.Clinical endocrinology (Oxford. Print). 2004, Vol 61, Num 1, pp 40-45, issn 0300-0664, 6 p.Article

Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter proteinTONACCHERA, Massimo; AGRETTI, Patrizia; PANUNZI, Claudio et al.Clinical endocrinology (Oxford. Print). 2003, Vol 59, Num 4, pp 500-506, issn 0300-0664, 7 p.Article

Dexamethasone stimulation of retinoic acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cellsUNTERHOLZNER, S; WILLHAUCK, M. J; CENGIC, N et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 1, pp 69-78, issn 0021-972X, 10 p.Article

A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue- specific sodium iodide symporter gene expressionCENGIC, Neziha; BAKER, Claire H; SCHUTZ, Martin et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 8, pp 4457-4464, issn 0021-972X, 8 p.Article

Regulation of iodide uptake and sodium/iodide symporter expression in the MCF-7 human breast cancer cell lineARTURI, Franco; FERRETTI, Elisabetta; RUSSO, Diego et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 4, pp 2321-2326, issn 0021-972X, 6 p.Article

In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven Expression of the sodium iodide symporterDWYER, Roisin M; BERGERT, Elizabeth R; O'CONNOR, Michael K et al.Clinical cancer research. 2005, Vol 11, Num 4, pp 1483-1489, issn 1078-0432, 7 p.Article

Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulinFURUYA, Fumihiko; SHIMURA, Hiroki; SUZUKI, Hideyo et al.Endocrinology (Philadelphia). 2004, Vol 145, Num 6, pp 2865-2875, issn 0013-7227, 11 p.Article

Low expression of sodium iodide symporter identifies aggressive thyroid tumorsWARD, Laura S; SANTAROSA, Patricia L; GRANJA, Fabiana et al.Cancer letters. 2003, Vol 200, Num 1, pp 85-91, issn 0304-3835, 7 p.Article

Use of sodium iodide symporter expression in differentiated thyroid carcinomasMORARI, Elaine C; MARCELLO, Marjory A; GUILHEN, Ana Carolina T et al.Clinical endocrinology (Oxford. Print). 2011, Vol 75, Num 2, pp 247-254, issn 0300-0664, 8 p.Article

Signaling through 3', 5'-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancerKNOSTMAN, Katherine A. B; CHO, Je-Yoel; HWANG, Dae Y et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 10, pp 5196-5203, issn 0021-972X, 8 p.Article

Extending the clinical heterogeneity of iodide transport defect (ITD) : A novel mutation R124H of the sodium/iodide symporter gene and review of genotype- phenotype correlations in ITDSZINNAI, Gabor; KOSUGI, Shinji; DERRIEN, Christèle et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 4, pp 1199-1204, issn 0021-972X, 6 p.Article

Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acidELISEI, Rossella; VIVALDI, Agnese; CIAMPI, Raffaele et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 6, pp 2389-2395, issn 0021-972X, 7 p.Article

Effective cancer therapy with the α-particle emitter [²¹¹At]astatine in a mouse model of genetically modified sodium/iodide symporter- expressing tumorsPETRICH, Thorsten; QUINTANILLA-MARTINEZ, Leticia; KORKMAZ, Zekiye et al.Clinical cancer research. 2006, Vol 12, Num 4, pp 1342-1348, issn 1078-0432, 7 p.Article

Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in Wistar ratsFAIVRE, Jamila; CLERC, Jérome; GEROLAMI, René et al.Cancer research (Baltimore). 2004, Vol 64, Num 21, pp 8045-8051, issn 0008-5472, 7 p.Article

Forskolin, 8-Br-3', 5'-cyclic adenosine 5'-monophosphate, and catalytic protein kinase A expression in the nucleus increase radioiodide uptake and sodium/iodide symporter protein levels in RET/PTC1-expressing cellsVENKATESWARAN, Anjli; MARSEE, Derek K; GREEN, Steven H et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 12, pp 6168-6172, issn 0021-972X, 5 p.Article